The predictive role of C-reactive protein in patients with hypertension and subclinical atherosclerosis

Internal Medicine Journal

Volumn 39, Issue 8, 2009, Pages 539-545

  Rizzo, M ^a   Corrado, E ^b   Coppola, G ^b   Muratori, I ^b   Mezzani, A ^a   Novo, G ^b   Novo, S ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b IRCCS   (Italy)

Author keywords

Atherosclerosis; C reactive protein; Event; Hypertension; Inflammation

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SMOKING;

AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 69549095944     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2009.01955.x     Document Type: Article

References (35)

1. Corrado E, Novo S. Role of inflammation and infection in vascular disease. Acta Chir Belg 2005 105 : 567 579.
2. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999 99 : 237 242.
3. Folsom AR, Aleksic N, Catellier D, Folsom AR, Aleksic N, Catellier D. C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 2002 144 : 233 238. (Pubitemid 34879645)
4. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998 97 : 2007 2011.
5. National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002 106 : 3143 3421.
6. Engstrom G, Lind P, Hedblad B, Stavenow L, Janzon L, Lindgarde F. Long-term effects of inflammation-sensitive plasma proteins and systolic blood pressure on incidence of stroke. Stroke 2002 33 : 2744 2749. (Pubitemid 35462837)
7. Bautista LE, López-Jaramillo P, Vera LM, Casas JP, Otero AP, Guaracao AI. Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens 2001 19 : 857 861.
8. European Society of Hypertension/European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003 21 : 1011 1053.
9. Hashimoto H, Kitagawa K, Hougaku H, Etani H, Hori M. Relationship between C-reactive protein and progression of early carotid atherosclerosis in hypertensive subjects. Stroke 2004 35 : 1625 1630.
10. Choi H, Cho DH, Shin HH, Park JB. Association of high sensitivity C-reactive protein with coronary heart disease prediction, but not with carotid atherosclerosis, in patients with hypertension. Circ J 2004 68 : 297 303.
11. Murata M, Ide T. Determination of cholesterol in sub-nanomolar quantities in biological fluids by high-performance liquid chromatography. J Chromatogr 1992 579 : 329 333.
12. Montagne P, Laroche P, Cuilliere ML, Varcin P, Duheille J. Microparticle-enhanced nephelometric immunoassay for human C- reactive protein. J Clin Lab Anal 1992 1 : 24 9.
13. Myers GL, Rifai N, Tracy R, Roberts WL, Alexander RW, Biasucci L et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease Application to Clinical and Public Health Practice Report From the Laboratory Science Discussion Group. Circulation 2004 110 : e545 9.
14. Corrado E, Rizzo M, Tantillo R, Muratori I, Bonura F, Vitale G et al. Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5 years follow-up study. Stroke 2006 37 : 482 486.
15. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall. A direct measurement with ultrasound imaging. Circulation 1986 74 : 1399 1406.
16. Corrado E, Rizzo M, Muratori I, Coppola G, Novo S. Association of elevated fibrinogen and C-reactive protein levels with carotid lesions in patients with newly diagnosed hypertension or type-II diabetes. Arch Med Res 2006 37 : 1004 1009.
17. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002 105 : 1135 1143.
18. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001 103 : 1813 1818.
19. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999 340 : 14 22.
20. Burke GL, Evans GW, Riley WA, Sharrett AR, Howard G, Barnes RW et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke 1995 26 : 386 391.
21. Bard RL, Kalsi H, Rubenfire MD, Brook RD. Effect of carotid atherosclerosis screening on risk stratification during primary cardiovascular disease prevention. Am J Cardiol 2004 93 : 1030 1032.
22. Sellmayer A, Limmert T, Hoffmann U. High sensitivity C-reactive protein in cardiovascular risk assessment. Int Angiol 2003 22 : 15 23.
23. Norris JW, Zhu CZ, Bornstein NM, Chambers BR. Vascular risks of asymptomatic carotid stenosis. Stroke 1991 22 : 1485 1490.
24. Magyar MT, Szikszai Z, Balla J, Valikovics A, Kappelmayer J, Imre S et al. Early-onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers. Stroke 2003 34 : 58 63.
25. Coppola G, Corrado E, Muratori I, Tantillo R, Vitale G, Lo Coco L et al. Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM. Int J Card 2006 106 : 16 20.
26. Skowasch D, Jabs A, Andrie R, Luderitz B, Bauriedel G. Progression of native coronary plaques and in-stent restenosis are associated and predicted by increased pre-procedural C reactive protein. Heart 2005 91 : 535 536.
27. Liang KW, Sheu WH, Lee WL, Liu TJ, Ting CT, Chen YT et al. Coronary artery disease progression is associated with C-reactive protein and conventional risk factors but not soluble CD40 ligand. Can J Cardiol 2006 22 : 691 696.
28. Ridker P, Rifai N, Pfeffer M, Sacks F, Braunwald E. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation 1999 100 : 230 235.
29. Jialal D, Stein D, Balis D, Grundy S, Adams-Huet B, Devaraj S. Effect of hydroxymethyl glutaryl coenzyme A reductase inhibitor therapy on high sensitive C-reactive protein Levels. Circulation 2001 103 : 1933 1935.
30. Khera A, de Lemos JA, Peshock RM, Lo HS, Stanek HG, Murphy SA et al. Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation 2006 113 : 38 43.
31. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002 347 : 1557 1565.
32. Michalsen A, Lehmann N, Pithan C, Knoblauch NT, Moebus S, Kannenberg F et al. Mediterranean diet has no effect on markers of inflammation and metabolic risk factors in patients with coronary artery disease. Eur J Clin Nutr 2006 60 : 478 485.
33. García-Lorda P, Bulló M, Balanzà R, Salas-Salvadó J. C-reactive protein, adiposity and cardiovascular risk factors in a Mediterranean population. Int J Obes (Lond) 2006 30 : 468 474. (Pubitemid 43315811)
34. Schillinger M, Exner M, Mlekusch W, Sabeti S, Amighi J, Nikowitsch R et al. Inflammation and Carotid Artery - Risk for Atherosclerosis Study (ICARAS). Circulation 2005 111 : 2203 2209.
35. Alvarez Garcia BA, Ruiz C, Chacon P, Sabin JA, Matas M. High-sensitivity C-reactive protein in high-grade carotid stenosis: risk marker for unstable carotid plaque. J Vasc Surg 2003 38 : 1018 1024.